Skip to content
About
Management
Board of Directors
Scientific Advisory Board
Therapeutic Areas
Pipeline
OLX07010 in Rare Tauopathies
OLX07010 Alzheimer’s
Technology
MOA
Patents
News & Publications
Partners and Collaborators
Contact Us
Menu
Study Might Point Alzheimer’s Research in Whole New Direction U.S. News
Home
>
News
>
Study Might Point Alzheimer’s Research in Whole New Direction U.S. News
Print
Oligomerix
>
News
>
Study Might Point Alzheimer’s Research in Whole New Direction U.S. News
Study Might Point Alzheimer’s Research in Whole New Direction U.S. News
Post navigation
Previous Post
Newly Discovered Drug Is Able To Inhibit Neurotoxic Tau Oligomers In Brains, Paving The Way For A Potential Cure for Alzheimer
Next Post
Oligomerix to Present at BIO CEO & Investor Conference, Tau2020 Global Conference
vera
View posts by vera
Leave a Reply
Cancel reply
You must be
logged in
to post a comment.
Scroll to top
close ×
